Hemophagocytic Lymphohistiocytosis, Immune Checkpoint Inhibitor, pembrolizumab, Ovarian Squamous Cell Carcinoma, Immune-Related Adverse Events
HIV, SIV, antibodies, neutralizing, rebound, ART, treatment interruption, viral control, children, infants, perinatal